[Aspergillus spondylodiscitis in a patient treated with ibrutinib]

Med Mal Infect. 2020 May;50(3):296-297. doi: 10.1016/j.medmal.2019.10.007. Epub 2019 Nov 10.
[Article in French]
No abstract available

Keywords: Aspergillose; Aspergillosis; Ibrutinib; Spondylodiscite; Spondylodiscitis.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenine / administration & dosage
  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Aged
  • Antifungal Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Aspergillosis / drug therapy
  • Aspergillosis / microbiology*
  • Aspergillosis / surgery
  • Aspergillus / drug effects
  • Aspergillus / isolation & purification*
  • Combined Modality Therapy
  • Discitis / drug therapy
  • Discitis / microbiology*
  • Discitis / surgery
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Laminectomy
  • Leukemia, Lymphocytic, Chronic, B-Cell / complications
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Male
  • Piperidines / administration & dosage
  • Piperidines / adverse effects*
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / adverse effects*
  • Rituximab / administration & dosage
  • Rituximab / adverse effects
  • Voriconazole / therapeutic use

Substances

  • Antifungal Agents
  • Immunosuppressive Agents
  • Piperidines
  • Protein Kinase Inhibitors
  • ibrutinib
  • Rituximab
  • Adenine
  • Voriconazole